Crossmark

Pharmacokinetics Screening, Molecular Docking, and Dynamics Simulations Revealed Novel Antimicrobial Peptide NKLF2 Mutants as Potent Inhibitors of Mycobacterium tuberculosis

Crossref DOI link: https://doi.org/10.1007/s12602-025-10608-0

Published Online: 2025-06-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

George, Elizabeth Annie https://orcid.org/0009-0005-7991-3447
Naha, Aniket https://orcid.org/0000-0002-6811-9767
Soundharya, H. https://orcid.org/0000-0003-4065-0254
Pallavi, Janardhan https://orcid.org/0009-0007-4851-291X
Menon, Anushka https://orcid.org/0009-0008-8071-9846
Anbarasu, Anand https://orcid.org/0000-0003-2216-7488
Ramaiah, Sudha https://orcid.org/0000-0002-4800-329X
Funding

Funding for this research was provided by:

Indian Council of Medical Research (IRIS ID: 2021-11889)
License Information

Text and Data Mining valid from 2025-06-11

Version of Record valid from 2025-06-11
More Information

Article History

Accepted: 22 May 2025

First Online: 11 June 2025

Declarations

:

: The authors declare no competing interests.